A Randomized Trial of Frovatriptan for the Intermittent Prevention of Menstrual Migraine

This study has been completed.
Sponsor:
Collaborator:
Vernalis (R&D) Ltd
Information provided by:
Endo Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00644033
First received: March 24, 2008
Last updated: June 13, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2002
  Primary Completion Date: June 2002 (Final data collection date for primary outcome measure)
No publications provided by Endo Pharmaceuticals

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):